Peter R. Hoffmann to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Peter R. Hoffmann has written about Drug Evaluation, Preclinical.
Connection Strength
0.124
-
Pugsley MK, Bhatt S, Gottfridsson C, Hoffmann P, Koshman YE, Norton K, O'Brien CE, Pierson J, Rossman EI, Taraboletti A, Zabka TS, Foley CM. Advancing nonclinical blood pressure assessment: Current practices and future directions in drug development. Regul Toxicol Pharmacol. 2026 Aug; 169:106098.
Score: 0.059
-
Lorthiois E, Roache J, Barnes-Seeman D, Altmann E, Hassiepen U, Turner G, Duvadie R, Hornak V, Karki RG, Schiering N, Weihofen WA, Perruccio F, Calhoun A, Fazal T, Dedic D, Durand C, Dussauge S, Fettis K, Tritsch F, Dentel C, Druet A, Liu D, Kirman L, Lachal J, Namoto K, Bevan D, Mo R, Monnet G, Muller L, Zessis R, Huang X, Lindsley L, Currie T, Chiu YH, Fridrich C, Delgado P, Wang S, Hollis-Symynkywicz M, Berghausen J, Williams E, Liu H, Liang G, Kim H, Hoffmann P, Hein A, Ramage P, D'Arcy A, Harlfinger S, Renatus M, Ruedisser S, Feldman D, Elliott J, Sedrani R, Maibaum J, Adams CM. Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach. J Med Chem. 2020 08 13; 63(15):8088-8113.
Score: 0.039
-
Bendjama K, Guionaud S, Aras G, Arber N, Badimon L, Bamberger U, Bratfalean D, Brott D, David M, Doessegger L, Firat H, Gallas JF, Gautier JC, Hoffmann P, Kraus S, Padro T, Saadoun D, Szczesny P, Thomann P, Vilahur G, Lawton M, Cacoub P. Translation strategy for the qualification of drug-induced vascular injury biomarkers. Toxicol Pathol. 2014 Jun; 42(4):658-71.
Score: 0.026